These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


229 related items for PubMed ID: 441720

  • 1. [Bartter's syndrome: Recurrence in the course of a treatment inhibiting prostaglandin synthesis].
    Favre L, Glasson P, Flory ED, Dray F, Vallotton MB.
    Schweiz Med Wochenschr; 1979 Feb 03; 109(5):142-7. PubMed ID: 441720
    [Abstract] [Full Text] [Related]

  • 2. Effect of indomethacin in a patient with Bartter's syndrome: evidence against a primary role of prostaglandin in this disorder.
    Etzioni A, Chaimovitz C, Levi Y, Benderli A, Better OS.
    Pediatr Res; 1980 Dec 03; 14(12):1395-7. PubMed ID: 7010289
    [Abstract] [Full Text] [Related]

  • 3. Treatment of Bartter's syndrome with indomethacin.
    Garin EH, Fennell RS, Iravani A, Richard GA.
    Am J Dis Child; 1980 Mar 03; 134(3):258-61. PubMed ID: 6767392
    [Abstract] [Full Text] [Related]

  • 4. [Plasma and urinary prostaglandins in Bartter's and pseudo-Bartter's syndrome (author's transl)].
    Hornych A.
    Nephrologie; 1980 Mar 03; 1(3):113-6. PubMed ID: 6945487
    [Abstract] [Full Text] [Related]

  • 5. Prostaglandin synthetase inhibitors in Bartter's syndrome. Effect on immunoreactive prostaglandin E excretion.
    Bowden RE, Gill JR, Radfar N, Taylor AA, Keiser HR.
    JAMA; 1978 Jan 09; 239(2):117-21. PubMed ID: 412983
    [Abstract] [Full Text] [Related]

  • 6. The role of prostaglandins in Bartter's syndrome.
    Winterborn MH, Hewitt GJ, Mitchell MD.
    Int J Pediatr Nephrol; 1984 Mar 09; 5(1):31-8. PubMed ID: 6370882
    [Abstract] [Full Text] [Related]

  • 7. [Bartter's syndrome: the long term effects of indomethacin on growth (author's transl)].
    Floret D, David M, Roux A, Hage GN, Teyssier G.
    Nouv Presse Med; 1979 Jan 06; 8(1):17-21. PubMed ID: 122007
    [Abstract] [Full Text] [Related]

  • 8. On the pathogenetic role of prostaglandins in Bartter's syndrome.
    Nielsen I, Hesse B, Christensen P.
    Acta Med Scand Suppl; 1979 Jan 06; 625():135-40. PubMed ID: 285569
    [Abstract] [Full Text] [Related]

  • 9. Indomethacin in Bartter's syndrome: does the syndrome represent a state of hyperprostaglandinism?
    Donker AJ, de Jong PE, van Eps LW, Brentjens JR, Bakker K, Doorenbos H.
    Nephron; 1977 Jan 06; 19(4):200-13. PubMed ID: 917167
    [Abstract] [Full Text] [Related]

  • 10. Bartter's syndrome with normal urinary excretion of prostaglandin E: therapeutic effects of propranolol, spironolactone, indomethacin and potassium chloride.
    Sato M, Abe K, Yasujima M, Otsuka Y, Chiba S, Haruyama T, Yoshinaga K, Saito T, Kabuki J.
    Tohoku J Exp Med; 1980 Jun 06; 131(2):151-9. PubMed ID: 7404582
    [Abstract] [Full Text] [Related]

  • 11. Prostaglandin E excretion and inhibition of prostaglandin synthesis in Bartter's syndrome.
    Hsieh BS, Chen WY, Yen TS, Lai MS.
    Taiwan Yi Xue Hui Za Zhi; 1978 Nov 06; 77(11):831-8. PubMed ID: 284093
    [No Abstract] [Full Text] [Related]

  • 12. [Bartter's syndrome. Failure of aspirin and success of indomethacin].
    Jáuregui WO, Di Fonzo P, Marchissio ML, Roehr E, Hauger-Klevene JH.
    Medicina (B Aires); 1979 Nov 06; 39(4):447-56. PubMed ID: 397398
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacologic studies in Bartter's syndrome: opposite effects of treatment with antikaliuretic and antiprostaglandin drugs. Part I.
    Simatupang TA, Radó JP, Boer P, Geyskes GG, Vos J, Dorhout Mees EJ.
    Int J Clin Pharmacol Biopharm; 1978 Jan 06; 16(1):14-8. PubMed ID: 631965
    [Abstract] [Full Text] [Related]

  • 14. Bartter's syndrome: a disorder characterized by high urinary prostaglandins and a dependence of hyperreninemia on prostaglandin synthesis.
    Gill JR, Frölich JC, Bowden RE, Taylor AA, Keiser HR, Seyberth HW, Oates JA, Bartter FC.
    Am J Med; 1976 Jul 06; 61(1):43-51. PubMed ID: 820194
    [Abstract] [Full Text] [Related]

  • 15. Long-term use of propranolol, ibuprofen, and spironolactone in the management of Bartter's syndrome.
    Cunningham RJ, Brouhard BH, Berger M, Petrusick T, Travis LB.
    Pediatrics; 1979 May 06; 63(5):754-6. PubMed ID: 440896
    [Abstract] [Full Text] [Related]

  • 16. Effect of indomethacin on urinary kallikrein excretion in Bartter's syndrome of the adult.
    Lechi A, Mantero F, Opocher G, Armanini D, Lechi C, Covi G.
    J Endocrinol Invest; 1981 May 06; 4(1):17-20. PubMed ID: 7016967
    [Abstract] [Full Text] [Related]

  • 17. Prostaglandins and aspirin therapy in Bartter's syndrome.
    Norby L, Flamenbaum W, Lentz R, Ramwell P.
    Lancet; 1976 Sep 18; 2(7986):604-6. PubMed ID: 61344
    [Abstract] [Full Text] [Related]

  • 18. [Value and limitations of indomethacin in the treatment of Bartter's syndrome].
    Dequiedt P, Lefebvre J, Raviart B, Vanhille P, Lepoutre E, Lelièvre G, Tacquet A.
    J Urol Nephrol (Paris); 1977 Sep 18; 83(9):688-93. PubMed ID: 926230
    [No Abstract] [Full Text] [Related]

  • 19. Free dopamine excretion in disorders with increased prostaglandin synthesis.
    Güllner HG.
    Prostaglandins Leukot Med; 1982 Jun 18; 8(6):545-51. PubMed ID: 6955810
    [Abstract] [Full Text] [Related]

  • 20. On the pathogenesis of Bartter's syndrome: report of studies in a patient with this disorder.
    Norby L, Mark AL, Kaloyanides GJ.
    Clin Nephrol; 1976 Sep 18; 6(3):404-13. PubMed ID: 991467
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.